Loading…
Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice
Obesity is a risk factor for colorectal cancer (CRC). The role of gut microbiota in mediating the cancer-promoting effect of obesity is unknown. Azoxymethane (AOM)-treated, ApcMin/+ and germ-free mice were gavaged with feces from obese individuals and control subjects respectively. The colonic tumor...
Saved in:
Published in: | EBioMedicine 2023-07, Vol.93, p.104670-104670, Article 104670 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c460t-b2209791cf2173c04fe5a5bf302a43d92cb9ca652d10048786249331a1c1460c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c460t-b2209791cf2173c04fe5a5bf302a43d92cb9ca652d10048786249331a1c1460c3 |
container_end_page | 104670 |
container_issue | |
container_start_page | 104670 |
container_title | EBioMedicine |
container_volume | 93 |
creator | Kang, Xing Ng, Siu-Kin Liu, Changan Lin, Yufeng Zhou, Yunfei Kwong, Thomas N.Y. Ni, Yunbi Lam, Thomas Y.T. Wu, William K.K. Wei, Hong Sung, Joseph J.Y. Yu, Jun Wong, Sunny H. |
description | Obesity is a risk factor for colorectal cancer (CRC). The role of gut microbiota in mediating the cancer-promoting effect of obesity is unknown.
Azoxymethane (AOM)-treated, ApcMin/+ and germ-free mice were gavaged with feces from obese individuals and control subjects respectively. The colonic tumor load and number were recorded at the endpoint in two carcinogenic models. The gut microbiota composition and colonic transcriptome were assessed by metagenomic sequencing and RNA sequencing, respectively. The anticancer effects of bacteria depleted in fecal samples of obese individuals were validated.
Conventional AOM-treated and ApcMin/+ mice receiving feces from obese individuals showed significantly increased colon tumor formation compared with those receiving feces from control subjects. AOM-treated mice receiving feces from obese individuals showed impaired intestinal barrier function and significant upregulation of pro-inflammatory cytokines and activation of oncogenic Wnt signaling pathway. Consistently, transferring feces from obese individuals to germ-free mice led to increased colonic cell proliferation, intestinal barrier function impairment, and induction of oncogenic and proinflammatory gene expression. Moreover, germ-free mice transplanted with feces from obese human donors had increased abundance of potential pathobiont Alistipes finegoldii, and reduced abundance of commensals Bacteroides vulgatus and Akkermansia muciniphila compared with those receiving feces from human donors with normal body mass index (BMI). Validation experiments showed that B. vulgatus and A. muciniphila demonstrated anti-proliferative effects in CRC, while A. finegoldii promoted CRC tumor growth.
Our results supported the role of obesity-associated microbiota in colorectal carcinogenesis and identified putative bacterial candidates that may mediate its mechanisms. Microbiota modulation in obese individuals may provide new approaches to prevent or treat obesity-related cancers including CRC.
This work was funded by National Key Research and Development Program of China (2020YFA0509200/2020YFA0509203), National Natural Science Foundation of China (81922082), RGC Theme-based Research Scheme Hong Kong (T21-705/20-N), RGC Research Impact Fund Hong Kong (R4632-21F), RGC-CRF Hong Kong (C4039-19GF and C7065-18GF), RGC-GRF Hong Kong (14110819, 14111621), and NTU Start-Up Grant (021337-00001). |
doi_str_mv | 10.1016/j.ebiom.2023.104670 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10314234</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2352396423002359</els_id><sourcerecordid>2828774455</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-b2209791cf2173c04fe5a5bf302a43d92cb9ca652d10048786249331a1c1460c3</originalsourceid><addsrcrecordid>eNp9kUtLAzEUhYMottT-AkGydNOa17wWIqX4goIbuw6ZzJ2aMjOpSabQf29qq9SNq4STc78bzkHompIpJTS9W0-hNLadMsJ4VESakTM0ZDxhE16k4vzkPkBj79eEEJqIKOaXaMAzLjhP-RAtZ00ABxVe9QG3RjsbsUFhW2Nbgjdhh31frkEHjzfOtjaAx9o21kVJNVgrp01nV9BFs8em20PgCl3UqvEwPp4jtHx6fJ-_TBZvz6_z2WKiRUrCpGSMFFlBdc1oxjURNSQqKWtOmBK8KpguC63ShFWUEJFnecpEwTlVVNMI0HyEHg7cTV-2UGnoglON3DjTKreTVhn596UzH3Jlt5ISTmMYIhJujwRnP3vwQbbGa2ga1YHtvWQ5y7NMiCSJVn6wxpC8d1D_7qFE7kuRa_ldityXIg-lxKmb0y_-zvxUEA33BwPEoLYGnPTaQKehMvuMZWXNvwu-AMNDnzM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2828774455</pqid></control><display><type>article</type><title>Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice</title><source>ScienceDirect Journals</source><source>PubMed Central</source><creator>Kang, Xing ; Ng, Siu-Kin ; Liu, Changan ; Lin, Yufeng ; Zhou, Yunfei ; Kwong, Thomas N.Y. ; Ni, Yunbi ; Lam, Thomas Y.T. ; Wu, William K.K. ; Wei, Hong ; Sung, Joseph J.Y. ; Yu, Jun ; Wong, Sunny H.</creator><creatorcontrib>Kang, Xing ; Ng, Siu-Kin ; Liu, Changan ; Lin, Yufeng ; Zhou, Yunfei ; Kwong, Thomas N.Y. ; Ni, Yunbi ; Lam, Thomas Y.T. ; Wu, William K.K. ; Wei, Hong ; Sung, Joseph J.Y. ; Yu, Jun ; Wong, Sunny H.</creatorcontrib><description>Obesity is a risk factor for colorectal cancer (CRC). The role of gut microbiota in mediating the cancer-promoting effect of obesity is unknown.
Azoxymethane (AOM)-treated, ApcMin/+ and germ-free mice were gavaged with feces from obese individuals and control subjects respectively. The colonic tumor load and number were recorded at the endpoint in two carcinogenic models. The gut microbiota composition and colonic transcriptome were assessed by metagenomic sequencing and RNA sequencing, respectively. The anticancer effects of bacteria depleted in fecal samples of obese individuals were validated.
Conventional AOM-treated and ApcMin/+ mice receiving feces from obese individuals showed significantly increased colon tumor formation compared with those receiving feces from control subjects. AOM-treated mice receiving feces from obese individuals showed impaired intestinal barrier function and significant upregulation of pro-inflammatory cytokines and activation of oncogenic Wnt signaling pathway. Consistently, transferring feces from obese individuals to germ-free mice led to increased colonic cell proliferation, intestinal barrier function impairment, and induction of oncogenic and proinflammatory gene expression. Moreover, germ-free mice transplanted with feces from obese human donors had increased abundance of potential pathobiont Alistipes finegoldii, and reduced abundance of commensals Bacteroides vulgatus and Akkermansia muciniphila compared with those receiving feces from human donors with normal body mass index (BMI). Validation experiments showed that B. vulgatus and A. muciniphila demonstrated anti-proliferative effects in CRC, while A. finegoldii promoted CRC tumor growth.
Our results supported the role of obesity-associated microbiota in colorectal carcinogenesis and identified putative bacterial candidates that may mediate its mechanisms. Microbiota modulation in obese individuals may provide new approaches to prevent or treat obesity-related cancers including CRC.
This work was funded by National Key Research and Development Program of China (2020YFA0509200/2020YFA0509203), National Natural Science Foundation of China (81922082), RGC Theme-based Research Scheme Hong Kong (T21-705/20-N), RGC Research Impact Fund Hong Kong (R4632-21F), RGC-CRF Hong Kong (C4039-19GF and C7065-18GF), RGC-GRF Hong Kong (14110819, 14111621), and NTU Start-Up Grant (021337-00001).</description><identifier>ISSN: 2352-3964</identifier><identifier>EISSN: 2352-3964</identifier><identifier>DOI: 10.1016/j.ebiom.2023.104670</identifier><identifier>PMID: 37343363</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Azoxymethane - toxicity ; Carcinogenesis ; Colonic Neoplasms ; Colorectal cancer ; Colorectal Neoplasms - genetics ; Disease Models, Animal ; Gastrointestinal Microbiome ; Gut barrier ; Humans ; Mice ; Mice, Inbred C57BL ; Microbiota ; Obesity ; Obesity - complications ; Pro-inflammation</subject><ispartof>EBioMedicine, 2023-07, Vol.93, p.104670-104670, Article 104670</ispartof><rights>2023 The Authors</rights><rights>Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.</rights><rights>2023 The Authors 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-b2209791cf2173c04fe5a5bf302a43d92cb9ca652d10048786249331a1c1460c3</citedby><cites>FETCH-LOGICAL-c460t-b2209791cf2173c04fe5a5bf302a43d92cb9ca652d10048786249331a1c1460c3</cites><orcidid>0000-0002-3354-9310</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314234/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2352396423002359$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37343363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kang, Xing</creatorcontrib><creatorcontrib>Ng, Siu-Kin</creatorcontrib><creatorcontrib>Liu, Changan</creatorcontrib><creatorcontrib>Lin, Yufeng</creatorcontrib><creatorcontrib>Zhou, Yunfei</creatorcontrib><creatorcontrib>Kwong, Thomas N.Y.</creatorcontrib><creatorcontrib>Ni, Yunbi</creatorcontrib><creatorcontrib>Lam, Thomas Y.T.</creatorcontrib><creatorcontrib>Wu, William K.K.</creatorcontrib><creatorcontrib>Wei, Hong</creatorcontrib><creatorcontrib>Sung, Joseph J.Y.</creatorcontrib><creatorcontrib>Yu, Jun</creatorcontrib><creatorcontrib>Wong, Sunny H.</creatorcontrib><title>Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice</title><title>EBioMedicine</title><addtitle>EBioMedicine</addtitle><description>Obesity is a risk factor for colorectal cancer (CRC). The role of gut microbiota in mediating the cancer-promoting effect of obesity is unknown.
Azoxymethane (AOM)-treated, ApcMin/+ and germ-free mice were gavaged with feces from obese individuals and control subjects respectively. The colonic tumor load and number were recorded at the endpoint in two carcinogenic models. The gut microbiota composition and colonic transcriptome were assessed by metagenomic sequencing and RNA sequencing, respectively. The anticancer effects of bacteria depleted in fecal samples of obese individuals were validated.
Conventional AOM-treated and ApcMin/+ mice receiving feces from obese individuals showed significantly increased colon tumor formation compared with those receiving feces from control subjects. AOM-treated mice receiving feces from obese individuals showed impaired intestinal barrier function and significant upregulation of pro-inflammatory cytokines and activation of oncogenic Wnt signaling pathway. Consistently, transferring feces from obese individuals to germ-free mice led to increased colonic cell proliferation, intestinal barrier function impairment, and induction of oncogenic and proinflammatory gene expression. Moreover, germ-free mice transplanted with feces from obese human donors had increased abundance of potential pathobiont Alistipes finegoldii, and reduced abundance of commensals Bacteroides vulgatus and Akkermansia muciniphila compared with those receiving feces from human donors with normal body mass index (BMI). Validation experiments showed that B. vulgatus and A. muciniphila demonstrated anti-proliferative effects in CRC, while A. finegoldii promoted CRC tumor growth.
Our results supported the role of obesity-associated microbiota in colorectal carcinogenesis and identified putative bacterial candidates that may mediate its mechanisms. Microbiota modulation in obese individuals may provide new approaches to prevent or treat obesity-related cancers including CRC.
This work was funded by National Key Research and Development Program of China (2020YFA0509200/2020YFA0509203), National Natural Science Foundation of China (81922082), RGC Theme-based Research Scheme Hong Kong (T21-705/20-N), RGC Research Impact Fund Hong Kong (R4632-21F), RGC-CRF Hong Kong (C4039-19GF and C7065-18GF), RGC-GRF Hong Kong (14110819, 14111621), and NTU Start-Up Grant (021337-00001).</description><subject>Animals</subject><subject>Azoxymethane - toxicity</subject><subject>Carcinogenesis</subject><subject>Colonic Neoplasms</subject><subject>Colorectal cancer</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Disease Models, Animal</subject><subject>Gastrointestinal Microbiome</subject><subject>Gut barrier</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microbiota</subject><subject>Obesity</subject><subject>Obesity - complications</subject><subject>Pro-inflammation</subject><issn>2352-3964</issn><issn>2352-3964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kUtLAzEUhYMottT-AkGydNOa17wWIqX4goIbuw6ZzJ2aMjOpSabQf29qq9SNq4STc78bzkHompIpJTS9W0-hNLadMsJ4VESakTM0ZDxhE16k4vzkPkBj79eEEJqIKOaXaMAzLjhP-RAtZ00ABxVe9QG3RjsbsUFhW2Nbgjdhh31frkEHjzfOtjaAx9o21kVJNVgrp01nV9BFs8em20PgCl3UqvEwPp4jtHx6fJ-_TBZvz6_z2WKiRUrCpGSMFFlBdc1oxjURNSQqKWtOmBK8KpguC63ShFWUEJFnecpEwTlVVNMI0HyEHg7cTV-2UGnoglON3DjTKreTVhn596UzH3Jlt5ISTmMYIhJujwRnP3vwQbbGa2ga1YHtvWQ5y7NMiCSJVn6wxpC8d1D_7qFE7kuRa_ldityXIg-lxKmb0y_-zvxUEA33BwPEoLYGnPTaQKehMvuMZWXNvwu-AMNDnzM</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Kang, Xing</creator><creator>Ng, Siu-Kin</creator><creator>Liu, Changan</creator><creator>Lin, Yufeng</creator><creator>Zhou, Yunfei</creator><creator>Kwong, Thomas N.Y.</creator><creator>Ni, Yunbi</creator><creator>Lam, Thomas Y.T.</creator><creator>Wu, William K.K.</creator><creator>Wei, Hong</creator><creator>Sung, Joseph J.Y.</creator><creator>Yu, Jun</creator><creator>Wong, Sunny H.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3354-9310</orcidid></search><sort><creationdate>20230701</creationdate><title>Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice</title><author>Kang, Xing ; Ng, Siu-Kin ; Liu, Changan ; Lin, Yufeng ; Zhou, Yunfei ; Kwong, Thomas N.Y. ; Ni, Yunbi ; Lam, Thomas Y.T. ; Wu, William K.K. ; Wei, Hong ; Sung, Joseph J.Y. ; Yu, Jun ; Wong, Sunny H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-b2209791cf2173c04fe5a5bf302a43d92cb9ca652d10048786249331a1c1460c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Azoxymethane - toxicity</topic><topic>Carcinogenesis</topic><topic>Colonic Neoplasms</topic><topic>Colorectal cancer</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Disease Models, Animal</topic><topic>Gastrointestinal Microbiome</topic><topic>Gut barrier</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microbiota</topic><topic>Obesity</topic><topic>Obesity - complications</topic><topic>Pro-inflammation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kang, Xing</creatorcontrib><creatorcontrib>Ng, Siu-Kin</creatorcontrib><creatorcontrib>Liu, Changan</creatorcontrib><creatorcontrib>Lin, Yufeng</creatorcontrib><creatorcontrib>Zhou, Yunfei</creatorcontrib><creatorcontrib>Kwong, Thomas N.Y.</creatorcontrib><creatorcontrib>Ni, Yunbi</creatorcontrib><creatorcontrib>Lam, Thomas Y.T.</creatorcontrib><creatorcontrib>Wu, William K.K.</creatorcontrib><creatorcontrib>Wei, Hong</creatorcontrib><creatorcontrib>Sung, Joseph J.Y.</creatorcontrib><creatorcontrib>Yu, Jun</creatorcontrib><creatorcontrib>Wong, Sunny H.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>EBioMedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kang, Xing</au><au>Ng, Siu-Kin</au><au>Liu, Changan</au><au>Lin, Yufeng</au><au>Zhou, Yunfei</au><au>Kwong, Thomas N.Y.</au><au>Ni, Yunbi</au><au>Lam, Thomas Y.T.</au><au>Wu, William K.K.</au><au>Wei, Hong</au><au>Sung, Joseph J.Y.</au><au>Yu, Jun</au><au>Wong, Sunny H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice</atitle><jtitle>EBioMedicine</jtitle><addtitle>EBioMedicine</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>93</volume><spage>104670</spage><epage>104670</epage><pages>104670-104670</pages><artnum>104670</artnum><issn>2352-3964</issn><eissn>2352-3964</eissn><abstract>Obesity is a risk factor for colorectal cancer (CRC). The role of gut microbiota in mediating the cancer-promoting effect of obesity is unknown.
Azoxymethane (AOM)-treated, ApcMin/+ and germ-free mice were gavaged with feces from obese individuals and control subjects respectively. The colonic tumor load and number were recorded at the endpoint in two carcinogenic models. The gut microbiota composition and colonic transcriptome were assessed by metagenomic sequencing and RNA sequencing, respectively. The anticancer effects of bacteria depleted in fecal samples of obese individuals were validated.
Conventional AOM-treated and ApcMin/+ mice receiving feces from obese individuals showed significantly increased colon tumor formation compared with those receiving feces from control subjects. AOM-treated mice receiving feces from obese individuals showed impaired intestinal barrier function and significant upregulation of pro-inflammatory cytokines and activation of oncogenic Wnt signaling pathway. Consistently, transferring feces from obese individuals to germ-free mice led to increased colonic cell proliferation, intestinal barrier function impairment, and induction of oncogenic and proinflammatory gene expression. Moreover, germ-free mice transplanted with feces from obese human donors had increased abundance of potential pathobiont Alistipes finegoldii, and reduced abundance of commensals Bacteroides vulgatus and Akkermansia muciniphila compared with those receiving feces from human donors with normal body mass index (BMI). Validation experiments showed that B. vulgatus and A. muciniphila demonstrated anti-proliferative effects in CRC, while A. finegoldii promoted CRC tumor growth.
Our results supported the role of obesity-associated microbiota in colorectal carcinogenesis and identified putative bacterial candidates that may mediate its mechanisms. Microbiota modulation in obese individuals may provide new approaches to prevent or treat obesity-related cancers including CRC.
This work was funded by National Key Research and Development Program of China (2020YFA0509200/2020YFA0509203), National Natural Science Foundation of China (81922082), RGC Theme-based Research Scheme Hong Kong (T21-705/20-N), RGC Research Impact Fund Hong Kong (R4632-21F), RGC-CRF Hong Kong (C4039-19GF and C7065-18GF), RGC-GRF Hong Kong (14110819, 14111621), and NTU Start-Up Grant (021337-00001).</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>37343363</pmid><doi>10.1016/j.ebiom.2023.104670</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-3354-9310</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2352-3964 |
ispartof | EBioMedicine, 2023-07, Vol.93, p.104670-104670, Article 104670 |
issn | 2352-3964 2352-3964 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10314234 |
source | ScienceDirect Journals; PubMed Central |
subjects | Animals Azoxymethane - toxicity Carcinogenesis Colonic Neoplasms Colorectal cancer Colorectal Neoplasms - genetics Disease Models, Animal Gastrointestinal Microbiome Gut barrier Humans Mice Mice, Inbred C57BL Microbiota Obesity Obesity - complications Pro-inflammation |
title | Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A01%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Altered%20gut%20microbiota%20of%20obesity%20subjects%20promotes%20colorectal%20carcinogenesis%20in%20mice&rft.jtitle=EBioMedicine&rft.au=Kang,%20Xing&rft.date=2023-07-01&rft.volume=93&rft.spage=104670&rft.epage=104670&rft.pages=104670-104670&rft.artnum=104670&rft.issn=2352-3964&rft.eissn=2352-3964&rft_id=info:doi/10.1016/j.ebiom.2023.104670&rft_dat=%3Cproquest_pubme%3E2828774455%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c460t-b2209791cf2173c04fe5a5bf302a43d92cb9ca652d10048786249331a1c1460c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2828774455&rft_id=info:pmid/37343363&rfr_iscdi=true |